An in vivo study of novel bioactive peptides that inhibit the growth of escherichia coli

J. R. Walker, J. R. Roth, Elliot Altman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We have created a system in which synthetically produced novel bioactive peptides can be expressed in vivo in Escherichia coil Twenty thousand of these peptides were screened and 21 inhibitors were found that could inhibit the growth of E. coil on minimal media. The inhibitors could be placed into one of two groups, 1-day inhibitors, which were partially inhibitory, and 2-day inhibitors, which were completely inhibitory. Sequence analysis showed that two of the most potent inhibitors were actually peptide-protein chimeras in which the peptides had become fused to the 63 amino acid Rop protein which was also contained in the expression vector used in this study. Given that Rop is known to form an incredibly stable structure, it could be serving as a stabilizing motif for these peptides. Sequence analysis of the predicted coding regions from the next 10 most inhibitory peptides showed that four of the 10 peptides contained one or more proline residues either at or very near the C-terminal end of the peptide which could act to prevent degradation by peptidases. Collectively, based on what we observed in our screen of synthetic bioactive peptides that could prevent the growth of E. coil and what has been learned from structural studies of naturally occurring bioactive peptides, the presence of a stabilizing motif seems to be important for small peptides, if they are to be biologically active.

Original languageEnglish (US)
Pages (from-to)380-388
Number of pages9
JournalJournal of Peptide Research
Volume58
Issue number5
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Escherichia coli
Peptides
Growth
Sequence Analysis
Escherichia
Proline
Proteins
Peptide Hydrolases
Amino Acids
Degradation

Keywords

  • Bioactive
  • In vivo
  • Library
  • Peptide

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

An in vivo study of novel bioactive peptides that inhibit the growth of escherichia coli. / Walker, J. R.; Roth, J. R.; Altman, Elliot.

In: Journal of Peptide Research, Vol. 58, No. 5, 2001, p. 380-388.

Research output: Contribution to journalArticle

Walker, J. R. ; Roth, J. R. ; Altman, Elliot. / An in vivo study of novel bioactive peptides that inhibit the growth of escherichia coli. In: Journal of Peptide Research. 2001 ; Vol. 58, No. 5. pp. 380-388.
@article{3aefc2e43dbd4205a55a03e28515ef04,
title = "An in vivo study of novel bioactive peptides that inhibit the growth of escherichia coli",
abstract = "We have created a system in which synthetically produced novel bioactive peptides can be expressed in vivo in Escherichia coil Twenty thousand of these peptides were screened and 21 inhibitors were found that could inhibit the growth of E. coil on minimal media. The inhibitors could be placed into one of two groups, 1-day inhibitors, which were partially inhibitory, and 2-day inhibitors, which were completely inhibitory. Sequence analysis showed that two of the most potent inhibitors were actually peptide-protein chimeras in which the peptides had become fused to the 63 amino acid Rop protein which was also contained in the expression vector used in this study. Given that Rop is known to form an incredibly stable structure, it could be serving as a stabilizing motif for these peptides. Sequence analysis of the predicted coding regions from the next 10 most inhibitory peptides showed that four of the 10 peptides contained one or more proline residues either at or very near the C-terminal end of the peptide which could act to prevent degradation by peptidases. Collectively, based on what we observed in our screen of synthetic bioactive peptides that could prevent the growth of E. coil and what has been learned from structural studies of naturally occurring bioactive peptides, the presence of a stabilizing motif seems to be important for small peptides, if they are to be biologically active.",
keywords = "Bioactive, In vivo, Library, Peptide",
author = "Walker, {J. R.} and Roth, {J. R.} and Elliot Altman",
year = "2001",
doi = "10.1034/j.1399-3011.2001.00897.x",
language = "English (US)",
volume = "58",
pages = "380--388",
journal = "Chemical Biology and Drug Design",
issn = "1747-0277",
publisher = "Blackwell",
number = "5",

}

TY - JOUR

T1 - An in vivo study of novel bioactive peptides that inhibit the growth of escherichia coli

AU - Walker, J. R.

AU - Roth, J. R.

AU - Altman, Elliot

PY - 2001

Y1 - 2001

N2 - We have created a system in which synthetically produced novel bioactive peptides can be expressed in vivo in Escherichia coil Twenty thousand of these peptides were screened and 21 inhibitors were found that could inhibit the growth of E. coil on minimal media. The inhibitors could be placed into one of two groups, 1-day inhibitors, which were partially inhibitory, and 2-day inhibitors, which were completely inhibitory. Sequence analysis showed that two of the most potent inhibitors were actually peptide-protein chimeras in which the peptides had become fused to the 63 amino acid Rop protein which was also contained in the expression vector used in this study. Given that Rop is known to form an incredibly stable structure, it could be serving as a stabilizing motif for these peptides. Sequence analysis of the predicted coding regions from the next 10 most inhibitory peptides showed that four of the 10 peptides contained one or more proline residues either at or very near the C-terminal end of the peptide which could act to prevent degradation by peptidases. Collectively, based on what we observed in our screen of synthetic bioactive peptides that could prevent the growth of E. coil and what has been learned from structural studies of naturally occurring bioactive peptides, the presence of a stabilizing motif seems to be important for small peptides, if they are to be biologically active.

AB - We have created a system in which synthetically produced novel bioactive peptides can be expressed in vivo in Escherichia coil Twenty thousand of these peptides were screened and 21 inhibitors were found that could inhibit the growth of E. coil on minimal media. The inhibitors could be placed into one of two groups, 1-day inhibitors, which were partially inhibitory, and 2-day inhibitors, which were completely inhibitory. Sequence analysis showed that two of the most potent inhibitors were actually peptide-protein chimeras in which the peptides had become fused to the 63 amino acid Rop protein which was also contained in the expression vector used in this study. Given that Rop is known to form an incredibly stable structure, it could be serving as a stabilizing motif for these peptides. Sequence analysis of the predicted coding regions from the next 10 most inhibitory peptides showed that four of the 10 peptides contained one or more proline residues either at or very near the C-terminal end of the peptide which could act to prevent degradation by peptidases. Collectively, based on what we observed in our screen of synthetic bioactive peptides that could prevent the growth of E. coil and what has been learned from structural studies of naturally occurring bioactive peptides, the presence of a stabilizing motif seems to be important for small peptides, if they are to be biologically active.

KW - Bioactive

KW - In vivo

KW - Library

KW - Peptide

UR - http://www.scopus.com/inward/record.url?scp=0035188986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035188986&partnerID=8YFLogxK

U2 - 10.1034/j.1399-3011.2001.00897.x

DO - 10.1034/j.1399-3011.2001.00897.x

M3 - Article

VL - 58

SP - 380

EP - 388

JO - Chemical Biology and Drug Design

JF - Chemical Biology and Drug Design

SN - 1747-0277

IS - 5

ER -